TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: ocular involvement in IBD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of accidental perforations in surgical gloves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incident CVD events
Endpoint domain: Mortality/survival
Primary endpoint: Asthma self-efficacy scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: average total drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drinking consequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine response (HBsAb 10 IU/mL or greater at Week 28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mild cognitive impairment (MCI) or probable dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stability of coagulation factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Food choice scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of heart-healthy foods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3-year event-free survival (EFS) rates
Endpoint domain: Mortality/survival
Primary endpoint: morphologic complete remission (CR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VEGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Parental self-efficacy (PSE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HDV RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working capacity in hot-humid environment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comprehensive function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of hip fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Intraoperative and postoperative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intramedullary pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSATS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of FA-specific IgE sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Readmission rate for DKA
Endpoint domain: Adverse events/effects
Primary endpoint: Mean hospital charges
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Duration of vasoconstriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative cTnT rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Degrees of headache, rhinalgia and nasal obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of bleeding and nasal secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average epithelialization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of oxygen therapy
Endpoint domain: Resource use
Primary endpoint: Duration of effect of analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health behaviors related to diet and physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: D2 occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: extrapyramidal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: prolactin level elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: aortic pulse wave velocity (PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hemoglobin event rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Migraine Intensity (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of children with BMI above the 95th percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: nocturnal hypoglycaemia risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prednisone AUDTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADH scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TLV proportions for direct orders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TLV proportions for undirected orders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental venous plasma glucose (2‐h area under the curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reported hunger
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Postoperative tooth sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of participant-to nonpartner psychological aggression
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of participant-to nonpartner physical aggression
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of injury from nonpartner aggression
Endpoint domain: Adverse events/effects
Primary endpoint: Prolactin concentration change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cumulative 5-year disease-free rate
Endpoint domain: Mortality/survival
Primary endpoint: skin blood flow response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Itch Numeric Rating Scale score of 0
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Bath Ankylosing Spondylitis Disease Activity Index (total score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of septicemia after prostate biopsy
Endpoint domain: Adverse events/effects
Primary endpoint: Disease Activity Score in 28 joints (DAS28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD3-positive cells reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MMP13 expression reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 2 esophagitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Median recovery time for grade 1 esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of infertility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Spontaneous communication using picture cards, speech, or both
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous communication to request objects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KT 2000 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score for sialorrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year overall survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative alanine and aspartate aminotransferase concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Percentage of unresolved alarms at 30 min after 'No action'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in peripheral oxygen saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steepest-meridian keratometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased risk of death
Endpoint domain: Mortality/survival
Primary endpoint: increased risk of death from cardiac cause
Endpoint domain: Mortality/survival
Primary endpoint: Ulifloxacin mean concentrations in gynaecological tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(max) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t(max) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-QHI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plaque-free inter-dental sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cTFC immediately after PPCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of no reflow or slow flow after PPCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ST-segment resolution at 2 hours after procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily faecal concentrations of SMT19969
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse events classified as gastrointestinal disorders
Endpoint domain: Adverse events/effects
Primary endpoint: need for muscle relaxants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean probing pocket depth reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elimination of deep pockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for additional adjunctive therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: length of surgical recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: impaired mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: need for assistance for self-care
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median overall survival (OAS)
Endpoint domain: Mortality/survival
Primary endpoint: Early virological response (EVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total fracture rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge about osteoporosis risk factors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive blood cultures for organisms after haemorrhoidectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Transient postoperative pyrexia
Endpoint domain: Adverse events/effects
Primary endpoint: Serious complications from operative techniques
Endpoint domain: Adverse events/effects
Primary endpoint: Mean hair loss after photoepilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Severity of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pure-tone audiometry score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion times in the control test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pleural fluid loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H/M ratio increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-reflex inhibition immediately after stretching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-reflex inhibition at five minutes after stretching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilatory Efficiency (VE/VCO2 slope)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of asymptomatic bacteriuria
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of stable defect of myocardial perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral Blood Flow (CBF) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opacification quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-peptide AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOCA communication skills measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Risk of death or malignant arrhythmia
Endpoint domain: Mortality/survival
Primary endpoint: Maximum heart rate to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 3-year progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: burden of menopausal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct catheter tip positioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in child and family HRQL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall medication satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Economic impact items
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Decrease in HAM-D total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to pituitary stimulation (FSH, LH, prolactin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Child engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in depression scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of thrombocytopenia
Endpoint domain: Adverse events/effects
Primary endpoint: FFM hydration (TBW:FFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of stools per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Upper limb motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of a hemiparetic arm in daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maternal tissue iron depletion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative verbal numerical rating scale pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total fentanyl requirement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain scores for cystoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LF/HF ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of bleeding through the dressing
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of active bleeding upon dressing removal
Endpoint domain: Adverse events/effects
Primary endpoint: improvements in self-reported female sexual function
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Symptoms of chronic idiopathic ulcerative colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in IQ
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: FBG formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MCP-1 secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: successful activation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: diagnostic yield
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in pain-free/maximum walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine efficacy against HZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine efficacy against PHN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right ventricular systolic pressure (RVSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cognitive flexibility
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency and severity of RP attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digital ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of adopting behavior
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Relative risk of low back pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shift to a lower modified Rankin Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bronchial bacterial burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: care-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to return-to-normal maxillary lip/cheek sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to return-to-normal mandibular lip sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUMST difference at peak for EASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEAKST difference at peak for EASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in total eosinophils count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Elevated creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Family impact scores
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Total ECOHIS scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child impact scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: LYGs (Life Years Gained)
Endpoint domain: Mortality/survival
Primary endpoint: ICER (Incremental Cost-Effectiveness Ratio)
Endpoint domain: Resource use
Primary endpoint: QALY (Quality-Adjusted Life Years)
Endpoint domain: Resource use
Primary endpoint: peak claudication pain ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nadir CB temperature (NCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of LA‐RB creation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily consumption of rescue analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC score at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of gallbladder perforation
Endpoint domain: Adverse events/effects
Primary endpoint: Intraoperative volume blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Respiratory outbreaks
Endpoint domain: Adverse events/effects
Primary endpoint: Methicillin-resistant Staphylococcus aureus infections requiring hospital admission
Endpoint domain: Adverse events/effects
Primary endpoint: complete amnesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recollection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rescue analgesia requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum IGFBP‐3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: blood sugar levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CyA trough levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of intradialytic hypotension (IDH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes